Standard
GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease : Randomized, placebo-controlled double-blinded clinical trial. / Gejl, M.; Egejord, L.; Møller, A.; Hansen, S. B.; Vang, K.; Rodell, A.; Brændgaard, H.; Gottrup, H.; Schacht, A.; Møller, N.; Brock, B.; Rungby, J.; Gjedde, A.
In:
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, No. Suppl 1, OP322, 2015.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Gejl, M, Egejord, L, Møller, A, Hansen, SB, Vang, K, Rodell, A, Brændgaard, H, Gottrup, H, Schacht, A, Møller, N, Brock, B, Rungby, J
& Gjedde, A 2015, '
GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial',
European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. Suppl 1, OP322.
https://doi.org/10.1007/s00259-015-3198-zAPA
Gejl, M., Egejord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., Møller, N., Brock, B., Rungby, J.
, & Gjedde, A. (2015).
GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial.
European Journal of Nuclear Medicine and Molecular Imaging,
42(Suppl 1), [OP322].
https://doi.org/10.1007/s00259-015-3198-zVancouver
Gejl M, Egejord L, Møller A, Hansen SB, Vang K, Rodell A et al.
GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial.
European Journal of Nuclear Medicine and Molecular Imaging. 2015;42(Suppl 1). OP322.
https://doi.org/10.1007/s00259-015-3198-zAuthor
Gejl, M. ; Egejord, L. ; Møller, A. ; Hansen, S. B. ; Vang, K. ; Rodell, A. ; Brændgaard, H. ; Gottrup, H. ; Schacht, A. ; Møller, N. ; Brock, B. ; Rungby, J. ; Gjedde, A. / GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease : Randomized, placebo-controlled double-blinded clinical trial. In: European Journal of Nuclear Medicine and Molecular Imaging. 2015 ; Vol. 42, No. Suppl 1.
Bibtex
@article{8b4ed3562a3b4eb8921684165147f424,
title = "GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer{\textquoteright}s Disease: Randomized, placebo-controlled double-blinded clinical trial",
author = "M. Gejl and L. Egejord and A. M{\o}ller and Hansen, {S. B.} and K. Vang and A. Rodell and H. Br{\ae}ndgaard and H. Gottrup and A. Schacht and N. M{\o}ller and B. Brock and J. Rungby and A. Gjedde",
year = "2015",
doi = "10.1007/s00259-015-3198-z",
language = "English",
volume = "42",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer",
number = "Suppl 1",
}
RIS
TY - ABST
T1 - GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease
T2 - Randomized, placebo-controlled double-blinded clinical trial
AU - Gejl, M.
AU - Egejord, L.
AU - Møller, A.
AU - Hansen, S. B.
AU - Vang, K.
AU - Rodell, A.
AU - Brændgaard, H.
AU - Gottrup, H.
AU - Schacht, A.
AU - Møller, N.
AU - Brock, B.
AU - Rungby, J.
AU - Gjedde, A.
PY - 2015
Y1 - 2015
U2 - 10.1007/s00259-015-3198-z
DO - 10.1007/s00259-015-3198-z
M3 - Conference abstract in journal
VL - 42
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
SN - 1619-7070
IS - Suppl 1
M1 - OP322
ER -
